| Literature DB >> 31879463 |
Natarajan Shanmugasundaram1, J Nivedhya1, Murugan Selvaraj Karthik1, Sathianathan Ramanathan1.
Abstract
Medication adherence with antipsychotics is adversely impacted by the burden of untoward adverse effects. In particular, sexual side effects are often underreported by patients, which may interfere with drug compliance. Presented here is the case of a 35-year-old male with schizophrenia, previously treated with risperidone following which he developed sexual dysfunction and hence was stopped. He was admitted to our psychiatric inpatient ward after a second psychotic exacerbation of the disorder after being drug free for about 6 months. On admission, treatment with risperidone was restarted, following which he developed retrograde ejaculation on oral risperidone therapy at a dose of 8 mg/day, with resolution of symptoms after cross tapering risperidone with lurasidone. Pharmacological interventions that may reduce antipsychotic-induced sexual dysfunction include changing the type of medication and administering other medications that are known to improve sexual dysfunction. This case emphasizes the need for routine inquiry into sexual dysfunction during atypical antipsychotic therapy. Copyright:Entities:
Keywords: Antipsychotic; lurasidone; retrograde ejaculation; risperidone; sexual dysfunction
Year: 2019 PMID: 31879463 PMCID: PMC6929214 DOI: 10.4103/ipj.ipj_8_19
Source DB: PubMed Journal: Ind Psychiatry J ISSN: 0972-6748